EcoDrugPlus

Cyclin D1

Ensembl ID : ENSONIG00000004126
Gene Symbol: CCND1
4 Cross references
206 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSONIG00000041456
Gene Symbol: CCND1
3 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSONIG00000009163
Gene Symbol: CDK1
4 Cross references
246 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSONIG00000019182
Gene Symbol: CDK4
4 Cross references
238 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSONIG00000009501
Gene Symbol: CDK5
4 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSONIG00000038572
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSONIG00000013709
Gene Symbol: CDK7
3 Cross references
218 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSONIG00000012601
Gene Symbol: CDK9
4 Cross references
207 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSONIG00000029954
Gene Symbol: CDK2
1 Cross references
202 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSONIG00000020586
Gene Symbol: CYSLTR1
1 Cross references
172 Possible Orthologues:

Cytidine Deaminase B

Ensembl ID : ENSONIG00000019357
Gene Symbol: CDAB
1 Cross references
200 Possible Orthologues:

Cytochrome P450 19a1-Like

Ensembl ID : ENSONIG00000000155
Gene Symbol: LOC100708217
3 Cross references
249 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).